Skip to content
MedicophiliaMedicophilia home

Topic Note

Amyloidosis: MRCP Part 2 Notes

Extracellular deposition of misfolded protein causing nephrotic syndrome, cardiac and multi-system disease — diagnosed by Congo red staining.

MRCP Part 2Nephrology5 min read

Definition

Amyloidosis is a group of disorders characterised by extracellular deposition of insoluble, misfolded protein in a β-pleated sheet configuration. Deposits accumulate in organs and progressively disrupt their function.

Main types

  • AL (primary) amyloidosisimmunoglobulin light chains produced by a clonal plasma cell disorder (associated with myeloma)
  • AA (secondary/reactive) amyloidosisserum amyloid A, an acute-phase reactant, deposited in the setting of chronic inflammation (rheumatoid arthritis, inflammatory bowel disease, chronic infection, familial Mediterranean fever)

Clinical presentation

Amyloidosis is a great multisystem mimic:

  • Renal: heavy proteinuria and nephrotic syndrome (kidneys often normal-sized or enlarged)
  • Cardiac: restrictive cardiomyopathy, heart failure, low-voltage ECG, conduction disease (a leading cause of death in AL)
  • Neurological: peripheral and autonomic neuropathy, carpal tunnel syndrome
  • GI/hepatic: hepatomegaly, malabsorption
  • AL-specific clues: macroglossia and periorbital purpura

Investigations

  • Biopsy with Congo red stain → apple-green birefringence under polarised light (the diagnostic hallmark); rectal or abdominal fat-pad biopsy is often used
  • Typing of the deposit (immunohistochemistry, mass spectrometry)
  • Serum free light chains and immunofixation for AL; screen for myeloma
  • SAP scintigraphy to assess distribution and monitor burden
  • Echocardiography and cardiac biomarkers for cardiac involvement

Management

  • AL: treat the plasma cell clone — chemotherapy regimens (e.g. bortezomib-based), sometimes autologous stem cell transplant
  • AA: treat the underlying inflammatory disease to lower serum amyloid A
  • Supportive management of organ failure (heart failure, nephrotic syndrome, dialysis)

MRCP-specific traps

  • Nephrotic syndrome with normal-sized or large kidneys should prompt thoughts of amyloid (or diabetes/HIV), not the small kidneys of most CKD.
  • Periorbital purpura and macroglossia point specifically to AL disease.
  • In AA amyloid, controlling the inflammatory driver can halt or even regress deposition.

Summary

Amyloidosis is misfolded-protein deposition — AL (light chains, plasma cell disorder) or AA (serum amyloid A, chronic inflammation). It causes nephrotic syndrome, restrictive cardiomyopathy and neuropathy. Diagnose with Congo red (apple-green birefringence); treat the clone in AL and the inflammation in AA.

nephrologyhaematologymultisystemmrcp part 2

Related reading

MRCP Part 2Nephrology

Renal Medicine MCQs: MRCP Part 2

Ten original single-best-answer renal questions with detailed explanations, spanning AKI, glomerulonephritis and electrolyte emergencies.

8 min readPractice Set
MRCP Part 2Nephrology

Polyuria: MRCP Part 2 Notes

Large urine volumes with a short differential — sort them into osmotic, water diuresis and drug causes.

3 min readTopic Note